000			01993 a2200529 4500
005			20250516022754.0
264		0	_c20111122
008			201111s 0 0 eng d
022			_a1432-0843
024	7		_a10.1007/s00280-011-1556-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aYoon, H H
245	0	0	_aGenetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _cOct 2011
300			_a863-70 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xgenetics
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aEsophageal Neoplasms _xgenetics
650	0	4	_aFemale
650	0	4	_aGenetic Variation
650	0	4	_aGlutathione S-Transferase pi _xgenetics
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPolymorphism, Single Nucleotide
650	0	4	_aRadiation Injuries
700	1		_aCatalano, P
700	1		_aGibson, M K
700	1		_aSkaar, T C
700	1		_aPhilips, S
700	1		_aMontgomery, E A
700	1		_aHafez, M J
700	1		_aPowell, M
700	1		_aLiu, G
700	1		_aForastiere, A A
700	1		_aBenson, A B
700	1		_aKleinberg, L R
700	1		_aMurphy, K M
773	0		_tCancer chemotherapy and pharmacology _gvol. 68 _gno. 4 _gp. 863-70
856	4	0	_uhttps://doi.org/10.1007/s00280-011-1556-5 _zAvailable from publisher's website
999			_c20565713 _d20565713